Nov 01, 2024
Exosens to Acquire NVLA, Manufacturer of Night Vision Devices - Novus Light Today
Exosens, a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, has announced the signing of the acquisition of Spain-based company
Exosens, a high-tech company focused on providing mission and performance-critical amplification, detection and imaging technology, has announced the signing of the acquisition of Spain-based company NVLS, a specialist developer and manufacturer of man-portable night vision and thermal devices.
Jérôme Cerisier, CEO of Exosens, commented, “With the acquisition of NVLS, we will enhance our long-term innovation capabilities for multi-sensor platforms using detectors and cameras made by Exosens.”
“Serving and delivering large volumes of high-performance image intensifiers to all our customers and end-users remain our priority in the years to come. We are committed to our customers to maintain the same high level of service and support that we have thrived to constantly deliver as the reference ITAR-free image intensifier tube provider,” he added.
NVLS, based in Spain with 63 employees, has developed a strong expertise in the field of man-portable night vision equipment, offering ultra-compact large field of view devices that provide enhanced visibility for land and aviation missions. These devices have been introduced as the new standards within the Spanish Armed Forces, Customs Police and Guardia Civil.
Jorge de la Torre, CEO of NVLS, said, “We are very pleased to join Exosens group with which we have built a strong supplier relationship since many years. All our products lines have always been using Photonis image intensifier tubes, which ensure a high level of image quality and reliability. We will continue to benefit from their extended sensors technology platform to develop a new generation of devices, bringing unrivaled performances to armed forces.”
The transaction is expected to be finalized in the coming months. Terms of the transaction are not being disclosed and are pending customary clearances and approvals.